Abstracts

VIRAL REBOUND KINETICS FOLLOWING SINGLE AND COMBINATION IMMUNOTHERAPY FOR HIV/SIV

HIV infection can be treated but not cured with antiretroviral therapy, motivating the development of new therapies that instead target host immune responses. Three such immunotherapies were recently tested in non-human primates – a TLR7-agonist, therapeutic vaccine (Ad26/MVA), and broadly-neutralizing antibody (PGT121) – and cured a subset of animals by preventing or controlling viral rebound…

QUANTITATIVE HIV-1 SPECIFIC ANTIBODIES AS PREDICTORS OF BLOOD HIV-1 DNA LEVELS

Antiretroviral therapy (ART) reduces HIV-1-related morbidity and mortality in children but does not prevent the establishment of a persistent replication-competent HIV-1 reservoir. Achieving low reservoir size is favorable for HIV-1 eradication efforts and sustained virologic remission. We evaluated the utility of using HIV-quantitative antibodies as a screening test for low circulating cell-associated HIV-1 DNA levels in…

INTACT PROVIRUSES FROM NAIVE AND EFFECTOR MEMORY T CELLS MATCH PERSISTENT VIREMIA

Genetically intact, and potentially replication competent, proviruses are a likely source for viremia during antiretroviral therapy (ART). Identifying the CD4+ T cell subsets that harbour these proviruses within different anatomic sites is important for future eradication strategies. Near full-length proviral sequences were obtained from naïve (NV), central (CM), transitional (TM) and effector memory (EM) CD4+…

A NOVEL DDPCR PROTOCOL TO ESTIMATE COPY NUMBERS OF POTENTIALLY INTACT HIV-1 PROVIRUS

Accurately quantifying the replication-competent HIV reservoir is essential for evaluating the efficacy of HIV cure strategies. Ideally, this should be achieved by a rapid turn-around high-throughput assay suitable for a clinical setting. We designed a multiplex ddPCR protocol to quantify potentially intact provirus in CD4+ T cells in ART-suppressed people living with HIV (PLWH). Our…

HIV TRANSCRIPTION PROFILE IN BLOOD, GUT, LIVER, AND GENITAL TRACT IN SUPPRESSED WOMEN

Sex-specific differences affect various aspects of HIV infection. However, few studies have quantified levels of HIV infection or expression in tissues from women.  Here, we measured the extent of HIV infection and progression through the HIV transcriptional blocks in blood, gut, liver, and genital tissues from HIV-infected ART-suppressed women. Peripheral blood mononuclear cells (PBMC), liver, gut…

RISK AND PREVALENCE OF RESIDUAL VIREMIA AFTER CART IN RESOURCE-LIMITED COUNTRIES

Tuberculosis, hepatitis B and C, sexually transmitted and tropical infections may contribute to higher residual viremia in virally suppressed people with HIV (PWH). The limited data describe residual viremia from low- and middle-income countries (LMIC). We assessed the prevalence, and factors associated with residual viremia in PWH, who were virally-suppressed on combination antiretroviral therapy (cART).…